Imperial College London
Alternate

ProfessorMarkJohnson

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Clinical Chair in Obstetrics
 
 
 
//

Contact

 

+44 (0)20 3315 7887mark.johnson

 
 
//

Location

 

H3.35Chelsea and Westminster HospitalChelsea and Westminster Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Cífková:2020:ehjcvp/pvz082,
author = {Cífková, R and Johnson, MR and Kahan, T and Brguljan, J and Williams, B and Coca, A and Manolis, A and Thomopoulos, C and Borghi, C and Tsioufis, C and Parati, G and Sudano, I and McManus, RJ and van, den Born B-JH and Regitz-Zagrosek, V and de, Simone G},
doi = {ehjcvp/pvz082},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
pages = {384--393},
title = {Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension},
url = {http://dx.doi.org/10.1093/ehjcvp/pvz082},
volume = {6},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Hypertensive disorders are the most common medical complications in the peripartum period associated with a substantial increase in morbidity and mortality. Hypertension in the peripartum period may be due to the continuation of pre-existing or gestational hypertension, de novo development of pre-eclampsia or it may be also induced by some drugs used for analgesia or suppression of postpartum haemorrhage. Women with severe hypertension and hypertensive emergencies are at high risk of life threatening complications, therefore, despite the lack of evidence-based data, based on expert opinion, antihypertensive treatment is recommended. Labetalol intravenously and metyldopa orally are then the two most frequently used drugs. Short-acting oral nifedipine is suggested to be used only if other drugs or iv access are not available. Induction of labour is associated with improved maternal outcome and should be advised for women with gestational hypertension or mild pre-eclampsia at 37 weeks gestation. This position paper provides the first interdisciplinary approach to the management of hypertension in the peripartum period based on the best available evidence and expert consensus.
AU  - Cífková,R
AU  - Johnson,MR
AU  - Kahan,T
AU  - Brguljan,J
AU  - Williams,B
AU  - Coca,A
AU  - Manolis,A
AU  - Thomopoulos,C
AU  - Borghi,C
AU  - Tsioufis,C
AU  - Parati,G
AU  - Sudano,I
AU  - McManus,RJ
AU  - van,den Born B-JH
AU  - Regitz-Zagrosek,V
AU  - de,Simone G
DO  - ehjcvp/pvz082
EP  - 393
PY  - 2020///
SN  - 2055-6845
SP  - 384
TI  - Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension
T2  - European Heart Journal - Cardiovascular Pharmacotherapy
UR  - http://dx.doi.org/10.1093/ehjcvp/pvz082
UR  - https://www.ncbi.nlm.nih.gov/pubmed/31841131
UR  - http://hdl.handle.net/10044/1/80173
VL  - 6
ER  -
Download